2.26
                                            Schlusskurs vom Vortag:
              $2.37
            Offen:
              $2.38
            24-Stunden-Volumen:
                588.34K
            Relative Volume:
              0.69
            Marktkapitalisierung:
                $204.00M
            Einnahmen:
              $70.14M
            Nettoeinkommen (Verlust:
              $-76.24M
            KGV:
              -2.036
            EPS:
                -1.11
            Netto-Cashflow:
                $-57.06M
            1W Leistung:
              -13.08%
            1M Leistung:
              -11.02%
            6M Leistung:
                -10.32%
            1J Leistung:
              -35.43%
            Codexis Inc Stock (CDXS) Company Profile
Firmenname
                  
                      Codexis Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      650-421-8100
                    
                Adresse
                  
                      200 PENOBSCOT DRIVE, REDWOOD CITY, CA
                    
                Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CDXS
                            
                             
                        Codexis Inc 
                           | 
                    2.26 | 213.93M | 70.14M | -76.24M | -57.06M | -1.11 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold | 
| 2024-06-03 | Fortgesetzt | Jefferies | Buy | 
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy | 
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold | 
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform | 
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight | 
| 2022-03-02 | Fortgesetzt | Cowen | Outperform | 
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight | 
| 2021-03-01 | Eingeleitet | Stifel | Buy | 
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy | 
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy | 
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform | 
| 2018-05-16 | Eingeleitet | Stephens | Overweight | 
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy | 
| 2017-05-31 | Eingeleitet | Jefferies | Buy | 
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight | 
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy | 
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy | 
                    Alle ansehen
                    
                  
                Codexis Inc Aktie (CDXS) Neueste Nachrichten
How to escape a deep drawdown in Codexis Inc.Market Performance Report & Verified Momentum Watchlists - newser.com
Can volume confirm reversal in Codexis Inc.Market Performance Summary & Weekly High Potential Alerts - newser.com
Is Codexis Inc. stock dividend yield sustainableJuly 2025 Rallies & Verified Momentum Stock Ideas - newser.com
Will Codexis Inc. stock outperform tech sector in 2025Market Growth Report & Reliable Price Action Trade Plans - newser.com
What MACD signals say about Codexis Inc.2025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
Is Codexis Inc. meeting your algorithmic filter criteriaEntry Point & Safe Capital Investment Plans - newser.com
Why Codexis Inc. stock is considered a top pickJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
How Codexis Inc. stock trades before earningsJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is Codexis Inc. stock a safe investment in uncertain markets2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
What risks investors should watch in Codexis Inc. stockJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Is Codexis Inc. forming a reversal patternRecession Risk & AI Forecast Swing Trade Picks - newser.com
How Codexis Inc. stock benefits from strong dollarJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
How hedge fund analytics apply to Codexis Inc. stockPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
How to use Fibonacci retracement on Codexis Inc.Quarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Detecting price anomalies in Codexis Inc. with AIEarnings Trend Report & Long Hold Capital Preservation Plans - newser.com
Strategies to average down on Codexis Inc.Analyst Upgrade & Verified Swing Trading Watchlists - newser.com
Codexis, Inc. $CDXS Position Boosted by Pier Capital LLC - MarketBeat
Will Codexis Inc. stock outperform Dow Jones index2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
How to build a dashboard for Codexis Inc. stockNew Guidance & Smart Money Movement Alerts - newser.com
Codexis (NASDAQ:CDXS investor five-year losses grow to 84% as the stock sheds US$29m this past week - simplywall.st
Will Codexis Inc. price bounce be sustainableJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
How Codexis Inc. stock reacts to oil pricesQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Can swing trading help recover from Codexis Inc. losses2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's Eco Synthesis®? Manufacturing Platform for Therapeutic siRNA Manufacturing - MarketScreener
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):